EN
ENOV
Enovis CORP
$22.94
-4.26%
$1.4B
No data for this timeframe.
Vol
Market Cap$1.4B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders6 funds
Inst. Value$319.0M
Inst. Activity1 buys / 0 sells
Insider Activity8B / 0S
Insider Net $$155.9K
SEC Reports4
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0001420800·Prev Close $23.96
Recent Activity
Jun 8, 2026
announcement
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens
The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corr
Jun 1, 2026
Insider
Engert Oliver bought 1,000 shares
Chief Administrative Officer @ $22.22 ($22.2K)
May 19, 2026
Insider
PERFALL A CLAYTON sold 9,346 shares
Director @ $0.00 ($0.00)
May 19, 2026
Insider
Kelly Liam sold 9,346 shares
Director @ $0.00 ($0.00)
May 7, 2026
SEC
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.82 by 8.5%, and revenue of $589M (+5.4% YoY), dri
8-K — Impact 6/10
May 7, 2026
SEC
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.81 by 9.9%, and revenue of $589M, beating $572.4M
PRESS-RELEASE — Impact 6/10
Apr 10, 2026
SEC
Enovis announced a Q4 2025 earnings press release with EPS of $0.95, beating consensus by 15.2%, though revenue and forw
PRESS-RELEASE — Impact 5/10
Inst.
FMR LLC — ADD
1,930,279 shares ($51.4M)
Price Targets
$43.00
+87.4% upside
Strong Buy
Current $22.94
Low $33.00
Median $40.00
High $55.00
11 analysts
$33.00
$55.00
Analyst Ratings
6Strong Buy
10Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 22, 2026 | BTIG | REITERATE | Buy → Buy |
| May 8, 2026 | Evercore ISI Group | MAINTAIN | Outperform → Outperform |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform → Outperform |
| Feb 26, 2026 | BTIG | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.85 ▼ -5.9% | $0.80 — $0.91 | 8% YoY | 12 |
| Next Q | $0.84 | $0.79 — $0.89 | 12% YoY | 12 |
| Current FY | $3.65 ▲ +1.1% | $3.59 — $3.72 | 11% YoY | 12 |
| Next FY | $4.06 ▲ +1.6% | $3.93 — $4.54 | 11% YoY | 12 |
Latest Reports
BULLISH
8-K
6/10
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.82 by 8.5%, and revenue of $589M (+5.4% YoY), dri
May 7, 2026
BULLISH
PRESS-RELEASE
6/10
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.81 by 9.9%, and revenue of $589M, beating $572.4M
May 7, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $171.5M | — |
| FMR LLC | $51.4M | ADD |
| BANK OF AMERICA CORP | $29.8M | — |
| MORGAN STANLEY | $29.4M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $25.4M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Engert Oliver | BUY | $22.2K |
| May 19, 2026 | PERFALL A | A | $0.00 |
| May 19, 2026 | Kelly Liam | A | $0.00 |
| May 19, 2026 | Wienbar Sharon | A | $0.00 |
| May 19, 2026 | Vinnakota Rajiv | A | $0.00 |
6 institutional holders with $319.0M total value (11,972,888 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 6,438,598 | $171.5M | 53.8% | — |
| 2 | FMR LLC | 1,930,279 | $51.4M | 16.1% | ADD +52.6% |
| 3 | BANK OF AMERICA CORP /DE/ | 1,118,085 | $29.8M | 9.3% | — |
| 4 | MORGAN STANLEY | 1,105,238 | $29.4M | 9.2% | TRIM -27.9% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 951,718 | $25.4M | 7.9% | NEW |
| 6 | WELLS FARGO & COMPANY/MN | 428,970 | $11.4M | 3.6% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 1,264,827 | 1,930,279 | +52.6% | $51.4M | 2025-Q4 |
| FMR LLC | DOUBLED | 6,370 | 1,264,827 | +19756.0% | $38.4M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 1,354,755 | 976,316 | -27.9% | $29.6M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 75,967 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 75,967 | — | $2.4M | 2025-Q2 |
| FMR LLC | TRIM | 10,268 | 6,370 | -38.0% | $199.8K | 2025-Q2 |
| MORGAN STANLEY | ADD | 830,809 | 1,106,229 | +33.2% | $42.3M | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 326,474 | 1,076,079 | +229.6% | $47.2M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 600,819 | — | $25.9M | 2024-Q3 |
17 unique insiders with 8 transactions. Net insider value: $155.9K ($155.9K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $22.22 | $22.2K |
| May 19, 2026 | PERFALL A CLAYTON | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Kelly Liam | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Wienbar Sharon L | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Vinnakota Rajiv | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Bodem Barbara W. | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Shirley Brady | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Okala Philip | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Ortiz Christine | Director | A | 9,346 | $0.00 | $0.00 |
| May 19, 2026 | Lalor Angela S | Director | A | 9,346 | $0.00 | $0.00 |
| May 12, 2026 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | F | 7,774 | $25.99 | $202.0K |
| May 12, 2026 | McDonald Damien | Chief Executive Officer | F | 12,634 | $25.99 | $328.4K |
| Mar 31, 2026 | Ortiz Christine | Director | A | 770 | $0.00 | $0.00 |
| Mar 13, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $23.74 | $23.7K |
| Mar 10, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $23.93 | $23.9K |
| Mar 9, 2026 | VOGT LOUIS | GROUP PRESIDENT, RECON | A | 36,247 | $0.00 | $0.00 |
| Mar 9, 2026 | Lang Patricia A | SVP, Chief HR Officer | A | 25,586 | $0.00 | $0.00 |
| Mar 9, 2026 | ROSS TERRY D | GROUP PRESIDENT, P&R | A | 36,247 | $0.00 | $0.00 |
| Mar 9, 2026 | KLECKNER JOHN | Principal Accounting Officer | A | 14,925 | $0.00 | $0.00 |
| Mar 9, 2026 | McDonald Damien | Chief Executive Officer | A | 143,923 | $0.00 | $0.00 |
| Mar 9, 2026 | Tandy Bradley J | SVP and Chief Legal Officer | A | 25,586 | $0.00 | $0.00 |
| Mar 9, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $23.39 | $23.4K |
| Mar 9, 2026 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | A | 47,974 | $0.00 | $0.00 |
| Mar 7, 2026 | KLECKNER JOHN | Principal Accounting Officer | F | 586 | $24.51 | $14.4K |
| Mar 7, 2026 | ROSS TERRY D | GROUP PRESIDENT, P&R | F | 2,376 | $24.51 | $58.2K |
| Mar 7, 2026 | Lang Patricia A | SVP, Chief HR Officer | F | 2,969 | $24.51 | $72.8K |
| Mar 7, 2026 | VOGT LOUIS | GROUP PRESIDENT, RECON | F | 1,980 | $24.51 | $48.5K |
| Mar 7, 2026 | Tandy Bradley J | SVP and Chief Legal Officer | F | 1,874 | $24.51 | $45.9K |
| Mar 7, 2026 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | F | 3,167 | $24.51 | $77.6K |
| Mar 6, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 250 | $24.28 | $6.1K |
| Mar 4, 2026 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | F | 2,220 | $25.79 | $57.3K |
| Mar 4, 2026 | Shirley Brady | Director | F | 3,059 | $25.79 | $78.9K |
| Mar 4, 2026 | ROSS TERRY D | GROUP PRESIDENT, P&R | F | 765 | $25.79 | $19.7K |
| Mar 4, 2026 | Tandy Bradley J | SVP and Chief Legal Officer | F | 1,102 | $25.79 | $28.4K |
| Mar 4, 2026 | KLECKNER JOHN | Principal Accounting Officer | F | 442 | $25.79 | $11.4K |
| Mar 4, 2026 | VOGT LOUIS | GROUP PRESIDENT, RECON | F | 888 | $25.79 | $22.9K |
| Mar 4, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 250 | $25.10 | $6.3K |
| Mar 4, 2026 | Lang Patricia A | SVP, Chief HR Officer | F | 1,173 | $25.79 | $30.3K |
| Mar 3, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $24.77 | $24.8K |
| Feb 28, 2026 | Tandy Bradley J | SVP and Chief Legal Officer | F | 484 | $25.47 | $12.3K |
| Feb 28, 2026 | KLECKNER JOHN | Principal Accounting Officer | F | 315 | $25.47 | $8.0K |
| Feb 28, 2026 | BERRY PHILLIP BENJAMIN (BEN) | SVP, Chief Financial Officer | F | 720 | $25.47 | $18.3K |
| Feb 28, 2026 | ROSS TERRY D | GROUP PRESIDENT, P&R | F | 418 | $25.47 | $10.6K |
| Feb 28, 2026 | Lang Patricia A | SVP, Chief HR Officer | F | 497 | $25.47 | $12.7K |
| Feb 28, 2026 | Shirley Brady | Director | F | 1,492 | $25.47 | $38.0K |
| Feb 28, 2026 | VOGT LOUIS | GROUP PRESIDENT, RECON | F | 889 | $25.47 | $22.6K |
| Feb 27, 2026 | Engert Oliver | Chief Administrative Officer | BUY | 1,000 | $25.50 | $25.5K |
4 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 2 mixed, 0 neutral. Avg impact: 6.0/10.
BULLISH
8-K
6/10
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.82 by 8.5%, and revenue of $5
May 7, 2026
BULLISH
PRESS-RELEASE
6/10
Enovis reported Q1 2026 adjusted EPS of $0.89, beating consensus of $0.81 by 9.9%, and revenue of $5
May 7, 2026
MIXED
PRESS-RELEASE
5/10
Enovis announced a Q4 2025 earnings press release with EPS of $0.95, beating consensus by 15.2%, tho
Apr 10, 2026
MIXED
8-K
7/10
Enovis reported full-year 2025 revenue growth of 7% (6% organically), driven by strong performance i
Feb 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (89% buy). Based on 18 analysts: 6 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$43.00 mean target
+87.4% upside
Strong Buy (3.00)
$33.00 Low
$55.00 High
| Metric | Value |
|---|---|
| Current Price | $22.94 |
| Target Low | $33.00 |
| Target Mean | $43.00 |
| Target Median | $40.00 |
| Target High | $55.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.85 | $0.80 | $0.91 | 7.8% | -5.9% | 1↑ 8↓ | $0.6B | 3.3% | 12 |
| Next Q 2026-09-30 |
$0.84 | $0.79 | $0.89 | 12.3% | -0.4% | 4↑ 5↓ | $0.6B | 2.6% | 12 |
| Current FY 2026-12-31 |
$3.65 | $3.59 | $3.72 | 10.5% | +1.1% | 7↑ 3↓ | $2.3B | 4.4% | 12 |
| Next FY 2027-12-31 |
$4.06 | $3.93 | $4.54 | 11.4% | +1.6% | 9↑ 1↓ | $2.5B | 5.3% | 12 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.851 | |
| 7d ago | $0.856 | -0.005 |
| 30d ago | $0.905 | -0.054 |
| 60d ago | $0.901 | -0.050 |
| 90d ago | $0.843 | +0.008 |
6 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 22, 2026 | BTIG | REITERATE | Buy | Buy |
| May 8, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 26, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 26, 2026 | Needham | MAINTAIN | Buy | Buy |
| Jan 6, 2026 | BTIG | INITIATE | — | Buy |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Dec 17, 2025 | Freedom Capital Markets | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| May 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Apr 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Mar 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Feb 1, 2026 | 6 | 10 | 2 | 0 | 0 | 89% | |
| Jan 1, 2026 | 5 | 10 | 2 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 8, 2026
announcement
Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens
The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable desi
Jun 2, 2026
short_volume
Short Volume: ENOV — 59.8% short (0.4M / 0.6M)
Short: 376,864 | Exempt: 0 | TRF Vol: 629,996 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: ENOV — 55.5% short (0.3M / 0.5M)
Short: 281,968 | Exempt: 0 | TRF Vol: 507,738 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: ENOV — 73.4% short (0.5M / 0.7M)
Short: 494,990 | Exempt: 0 | TRF Vol: 674,272 | Short Ratio: 73.4% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: ENOV — 62.4% short (0.4M / 0.6M)
Short: 353,266 | Exempt: 14 | TRF Vol: 566,015 | Short Ratio: 62.4% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: ENOV — 88.0% short (0.7M / 0.9M)
Short: 749,146 | Exempt: 0 | TRF Vol: 851,395 | Short Ratio: 88.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: ENOV — 77.6% short (0.5M / 0.6M)
Short: 480,794 | Exempt: 126 | TRF Vol: 619,293 | Short Ratio: 77.6% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings
Enovis Announces First Quarter 2026 Results
<p align="justify">Dallas, TX, May 07, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven m
May 7, 2026
earnings_calendar
ENOV Q1 2026 Earnings Before Market Open — 2026-05-07
May 7, 2026
short_volume
Short Volume: ENOV — 60.1% short (0.5M / 0.8M)
Short: 474,825 | Exempt: 0 | TRF Vol: 790,474 | Short Ratio: 60.1% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
short_volume
Short Volume: ENOV — 69.5% short (0.4M / 0.5M)
Short: 359,845 | Exempt: 0 | TRF Vol: 517,566 | Short Ratio: 69.5% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: ENOV — 82.6% short (0.6M / 0.7M)
Short: 596,697 | Exempt: 0 | TRF Vol: 722,561 | Short Ratio: 82.6% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
earnings
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
<p align="justify">Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth
Feb 26, 2026
earnings_calendar
ENOV Q4 2025 Earnings Before Market Open — 2026-02-26
Feb 6, 2026
short_interest
FTD: ENOV — 23,236 shares ($0.5M) failed to deliver
Settlement: 20260206, Price: $21.79, FTD Value: $506,312.44, ENOVIS CORPORATION COM NEW